Daljeet Singh

ALL
News
Opinion
Photos
Videos

Jump to

Capital First may move to Rs 468: Daljeet Singh Kohli

Daljeet Singh Kohli, Head of Research at India Nivesh Securities feels that Capital First may move to Rs 468.
Subscribe to Alkem Labs & Dr Lal Pathlabs: India Nivesh Sec

Daljeet Singh Kohli, HOR, India Nivesh Securites recommends subscribing to both Alkem Laboratories and Dr Lal Pathlabs IPOs.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Daljeet Singh

Capital First may move to Rs 468: Daljeet Singh Kohli

Subscribe to Alkem Labs & Dr Lal Pathlabs: India Nivesh Sec